InfasurfAero™
Non-Invasive Surfactant Delivery for RDS in Preterm Newborns
Phase 2/3Active
Key Facts
Indication
Non-Invasive Surfactant Delivery for RDS in Preterm Newborns
Phase
Phase 2/3
Status
Active
Company
About Ony Biotech
Founded in 1985 and based in Amherst, New York, ONY Biotech is a commercial-stage biotech specializing in neonatal respiratory care. Its core business is built on the FDA-approved surfactant Infasurf®, which has been a standard of care since 1998. The company is actively expanding its portfolio through clinical development of non-invasive surfactant delivery (InfasurfAero™) and partnerships for medical devices like the AerVia® Neonatal Airway, aiming to solidify its position as a leader in neonatology therapeutics and devices.
View full company profile